CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

21 hedge funds and large institutions have $14.6M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

80% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 10

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$897K
2 -$172K
3 -$87.3K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$84.7K
5
Citigroup
Citigroup
New York
-$45.6K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.98M
2
$1.25M
3
$621K
4
$588K
5
$570K
6
$477K
7
$469K
8
$372K
9
$268K
10
$240K
11
$222K
12
$165K
13
$115K
14
$82.6K
15
$58K
16
$50K
17
$40K
18
$26K
19
$8K
20
$5K
21
22